Post-traumatic stress disorder was associated with 4.2% to 9.3% higher annual per-patient healthcare costs compared with MDD among patients covered by Medicaid or private insurance.
Patients have an incomplete understanding of what constitutes no-cost preventive care services. Ease of obtaining information from insurance companies can significantly affect whether patients are charged correctly.
Lessons learned from implementation of a pharmacist-delivered medication therapy management intervention in primary care can inform future studies and be adopted into real-world clinical settings.
Medication formulary policies represent a key determinant of access to medication and can be leveraged to advance pharmacoequity and health equity writ large.
Systematic review and meta-analysis suggest that upper gastrointestinal symptoms and disorders are common to inhabitants of the United States.
Gaps in ACO implementation readiness are identified as appointment reminders, referral follow-ups, care management, care transition alerts, clinical quality measure knowledge, and resources.
Electronic health records data can accurately quantify overuse of clinical services and the risk factors that may trigger low-value testing and screening.
Clinical pharmacy specialists impact patient care through improvements in clinical outcomes for diabetes, hypertension, and dyslipidemia via clinical interventions and promotion of medication adherence.
Even among practices reaching the highest level of PCMH achievement, there are variations in the implementation of key medical home capabilities.
Scores on a new medication adherence scale maintained a strong graded association with antihypertensive drug pharmacy fill adherence among community-dwelling seniors in a managed care organization.
A pharmacist-led Medicare Medication Therapy Management program can improve clinical outcomes in Medicare beneficiaries without an increase in medication costs.